Ocular diseases of the anterior segment and adnexa in the elderly by Niurka Pérez Vázquez, Gelsy Castillo Bermúdez, Neyda Alina González Pérez, Yoan Ramos Ravelo

“…High blood pressure (37.4%) and age-related macular degeneration (27.6%) were evident. Decreased visual acuity occurred in 69.1% and cataract was the predominant disease (43.9%). …”
Get full text

Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering by Karim Ben M’Barek, Christelle Monville

“…Retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). …”
Get full text

Lutein and zeaxanthin complex: ophthalmologists’ choice by A.V. Korneeva

“…<br> <br> <b>Key words:</b> lutein, zeaxanthin, carotenoids, antioxidants, age-related macular degeneration.<br> <b>For citation:</b> Korneeva A.V. …”
Get full text

Selecting drug formulation for the treatment and prevention of retinal disorders by O.V. Filippova

“…Among them, age-related macular degeneration (AMD) leads to significant visual impairment and irreversible blindness in millions of patients worldwide. …”
Get full text

New possibilities of using methylaethylpiridinolum in ophthalmological practice by E.A. Egorov, A.A. Gvetadze

“…<br> <br> <b>Key words:</b> oxidative stress, reactive oxygen species, methylaethylpiridinolum, antioxidant, sodium hyaluronate, retinoprotection, diabetic retinopathy, glaucoma, age-related macular degeneration.<br> <b>For citation:</b> Egorov E.A., Gvetadze A.A. …”
Get full text

The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization by A.V. Kuroyedov, Zakharova M.A., O.V. Gapon’ko, V.V. Gorodnichiy

“…<br> <b>Patients and Methods:</b> 34 patients (40 eyes) with age-related macular degeneration were divided into 2 groups. Group 1 —&nbsp;the patients (19 eyes) with classic CNV, group 2 — the patients (21 eyes) with occult CNV. …”
Get full text

Future of artificial intelligence for the diagnosis and treatment of retinal diseases by E.A. Katalevskaya, D.Yu. Katalevskiy, M.I. Tyurikov, I.A. Velieva, A.V. Bol’shunov

“…., diabetic retinopathy, diabetic macular edema, age-related macular degeneration) to provide a personalized management strategy. …”
Get full text

Retinal Pigment Epithelium Transplantation: Past, Present, and Future by Ayyad Zartasht Khan, Tor Paaske Utheim, Jon Roger Eidet

“…Damaged RPE is associated with diseases such as age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa. …”
Get full text

Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases by Ming Yang, Yanling Wang

“…This article reviews the function and the potential mechanism of AST in dry eye syndrome, keratitis, cataract, diabetic retinopathy, age-related macular degeneration, high intraocular pressure, and other ocular diseases. …”
Get full text

Lutein and inflammation: a comprehensive review of its mechanisms of action by Paradentavida Prathyusha, Geetha Viswanathan, Anjilikal Tomy Tomcy, Ponnamparambil P. Binitha, Smitha V. Bava, Edakkadath R. Sindhu

“…Additionally, it discusses lutein’s beneficial impact on macular degeneration and eye diseases, showcasing its potential as a natural, plant-based therapeutic agent.…”
Get full text

The effects of antioxidants, angioprotective agents, and vitamins on retina in complex retinal diseases by I.V. Vorobyeva, A.A. Dement’eva, A. Dgebuadze

“…</i> </p> <p> <i><b>Keywords</b>: diabetic retinopathy, age-related macular degeneration, lutein, zeaxanthin, troxerutin, vitamins B, vitamin C, vitamin E, folic acid, zinc.…”
Get full text

Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations by Sanjay Sharma, David T Wong, Shaheer Aboobaker, David Maberley, Pradeepa Yoganathan

“…Dual inhibition of the angiopoietin (Ang)/Tie and vascular endothelial growth factor (VEGF) signalling pathways in patients with retinal diseases, such as neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME), may induce greater vascular stability and contribute to increased treatment efficacy and durability compared with treatments that only target the VEGF pathway. …”
Get full text

Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease by Nicole K. Scripsema, Dan-Ning Hu, Richard B. Rosen

“…Observational studies have reported that increased dietary intake and higher serum levels of lutein and zeaxanthin are associated with lower risk of age-related macular degeneration (AMD), especially late AMD. Randomized, placebo-controlled clinical trials have demonstrated that xanthophyll supplementation increases macular pigment levels, improves visual function, and decreases the risk of progression to late AMD, especially neovascular AMD. …”
Get full text

Therapeutic Effect of Oral Bisphosphonates on Choroidal Neovascularization in the Human Eye by Shigeru Honda, Takayuki Nagai, Naoshi Kondo, Masahide Fukuda, Sentaro Kusuhara, Yasutomo Tsukahara, Akira Negi

“…Choroidal neovascularization (CNV) is often associated with age-related macular degeneration (AMD) and pathological myopia (PM). …”
Get full text

Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen by Michael L. McCaleb, Steven G. Hughes, Tamar R. Grossman, Ashley Frazer-Abel, Bill Jung, Lixuan Yin, Scott P. Henry, Brett P. Monia, Eugene Schneider, Richard Geary, Gary T. Brice

“…These clinical results support the ongoing Phase 2 development for geographic atrophy secondary to age-related macular degeneration and Ph 2/3 development for IgA nephropathy.…”
Get full text

Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture by Mohammad-Reza Mahmoudian-Sani, Fatemeh Forouzanfar, Samira Asgharzade, Nilufar Ghorbani

“…Retinal degeneration is considered as a condition ensued by different blinding disorders such as retinitis pigmentosa, age-related macular degeneration, and diabetic retinopathy, which can cause loss of photoreceptor cells and also lead to significant vision deficiencies. …”
Get full text

Systems Biology Profiling of AMD on the Basis of Gene Expression by Mones S. Abu-Asab, Jose Salazar, Jingsheng Tuo, Chi-Chao Chan

“…Genetic pathways underlying the initiation and progression of age-related macular degeneration (AMD) have not been yet sufficiently revealed, and the correlations of AMD’s genotypes, phenotypes, and disease spectrum are still awaiting resolution. …”
Get full text

Anti-VEGF Treatment Strategies for Wet AMD by Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

“…Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. …”
Get full text

The rate of eye comorbidities in patients with cataracts (results of a population study) by M.M. Bikbov, O.I. Orenburkina, T.R. Gilmanshin, A.E. Babushkin

“…Among them, age-related macular degeneration (AMD) ranked first (13.46%). …”
Get full text

Focal Choroidal Elevations: Localized Pigment Epithelial Contour Alterations due to Isolated Choroidal Vessels by Rachel L. Chu, Nicole A. Pannullo, Eric J. Sigler

“…FCE were observed in 25 patients with age-related macular degeneration (ARMD), in 5 patients with high myopia, and in 8 patients with age-related choroidal atrophy (ARCA). …”
Get full text